Summary

Genotyping Assays Market – Scope of Report
TMR’s report on the global genotyping assays market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global genotyping assays market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global genotyping assays market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the genotyping assays market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global genotyping assays market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global genotyping assays market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global genotyping assays market.

The report delves into the competitive landscape of the global genotyping assays market. Key players operating in the global genotyping assays market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global genotyping assays market profiled in this report.

Key Questions Answered in Global genotyping assays Market Report
• What is the sales/revenue generated by genotyping assays across all regions during the forecast period?
• What are the opportunities in the global genotyping assays market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Genotyping Assays Market – Research Objectives and Research Approach
The comprehensive report on the global genotyping assays market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global genotyping assays market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global genotyping assays market.

ページTOPに戻る

Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Genotyping Assays Market
4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Genotyping Assays Market Analysis and Forecast, 2020-2034
5. Key Insights
    5.1. Pipeline Analysis
    5.2. Key Product/Brand Analysis
    5.3. Key Mergers & Acquisitions
    5.4. COVID-19 Pandemic Impact on Industry
6. Global Genotyping Assays Market Analysis and Forecast, by Product & Service
    6.1. Introduction and Definitions
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product & Service, 2020-2034
        6.3.1. Reagents & Kits
        6.3.2. Genotyping Services
        6.3.3. Instruments
            6.3.3.1. Sequences & Amplifiers
            6.3.3.2. Analyzers
        6.3.4. Bioinformatics
            6.3.4.1. Software
            6.3.4.2. Services
    6.4. Market Attractiveness, by Product & Service
7. Global Genotyping Assays Market Analysis and Forecast, by Technology
    7.1. Introduction and Definitions
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Technology, 2020-2034
        7.3.1. PCR
            7.3.1.1. Real-time PCR
            7.3.1.2. Digital PCR
        7.3.2. Microarrays
        7.3.3. Sequencing
            7.3.3.1. NGS
            7.3.3.2. Pyrosequencing
            7.3.3.3. Sanger Sequencing
        7.3.4. Capillary Electrophoresis
            7.3.4.1. Amplified Fragment Length Polymorphism
            7.3.4.2. Restricted Fragment Length Polymorphism
            7.3.4.3. Single-Stranded Conformation Polymorphism
        7.3.5. MALDI-TOF
        7.3.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
    7.4. Market Attractiveness, by Technology
8. Global Genotyping Assays Market Analysis and Forecast, by Application
    8.1. Introduction and Definitions
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Application, 2020-2034
        8.3.1. Pharmacogenomics
        8.3.2. Diagnostic & Personalized Medicine
        8.3.3. Agricultural Biotechnology
        8.3.4. Animal Genetics
        8.3.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
    8.4. Market Attractiveness, by Application
9. Global Genotyping Assays Market Analysis and Forecast, by End-user
    9.1. Introduction and Definitions
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by End-user, 2020-2034
        9.3.1. Pharmaceutical & Biopharmaceutical Companies
        9.3.2. Diagnostic & Research Laboratories
        9.3.3. Academic Institutes
        9.3.4. Others (Animal and Aquagenetics Companies, etc.)
    9.4. Market Attractiveness, by End-user
10. Global Genotyping Assays Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region, 2020-2034
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness, by Region
11. North America Genotyping Assays Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product & Service, 2020-2034
        11.2.1. Reagents & Kits
        11.2.2. Genotyping Services
        11.2.3. Instruments
            11.2.3.1. Sequences & Amplifiers
            11.2.3.2. Analyzers
        11.2.4. Bioinformatics
            11.2.4.1. Software
            11.2.4.2. Services
    11.3. Market Attractiveness, by Product & Service
    11.4. Market Value Forecast, by Technology, 2020-2034
        11.4.1. PCR
            11.4.1.1. Real-time PCR
            11.4.1.2. Digital PCR
        11.4.2. Microarrays
        11.4.3. Sequencing
            11.4.3.1. NGS
            11.4.3.2. Pyrosequencing
            11.4.3.3. Sanger Sequencing
        11.4.4. Capillary Electrophoresis
            11.4.4.1. Amplified Fragment Length Polymorphism
            11.4.4.2. Restricted Fragment Length Polymorphism
            11.4.4.3. Single-Stranded Conformation Polymorphism
        11.4.5. MALDI-TOF
        11.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
    11.5. Market Attractiveness, by Technology
    11.6. Market Value Forecast, by Application, 2020-2034
        11.6.1. Pharmacogenomics
        11.6.2. Diagnostic & Personalized Medicine
        11.6.3. Agricultural Biotechnology
        11.6.4. Animal Genetics
        11.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
    11.7. Market Attractiveness, by Application
    11.8. Market Value Forecast, by End-user, 2020-2034
        11.8.1. Pharmaceutical & Biopharmaceutical Companies
        11.8.2. Diagnostic & Research Laboratories
        11.8.3. Academic Institutes
        11.8.4. Others (Animal and Aquagenetics Companies, etc.)
    11.9. Market Attractiveness, by End-user
    11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
        11.10.1. U.S.
        11.10.2. Canada
    11.11. Market Attractiveness Analysis
        11.11.1. By Product & Service
        11.11.2. By Technology
        11.11.3. By Application
        11.11.4. By End-user
        11.11.5. By Country
12. Europe Genotyping Assays Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product & Service, 2020-2034
        12.2.1. Reagents & Kits
        12.2.2. Genotyping Services
        12.2.3. Instruments
            12.2.3.1. Sequences & Amplifiers
            12.2.3.2. Analyzers
        12.2.4. Bioinformatics
            12.2.4.1. Software
            12.2.4.2. Services
    12.3. Market Attractiveness, by Product & Service
    12.4. Market Value Forecast, by Technology, 2020-2034
        12.4.1. PCR
            12.4.1.1. Real-time PCR
            12.4.1.2. Digital PCR
        12.4.2. Microarrays
        12.4.3. Sequencing
            12.4.3.1. NGS
            12.4.3.2. Pyrosequencing
            12.4.3.3. Sanger Sequencing
        12.4.4. Capillary Electrophoresis
            12.4.4.1. Amplified Fragment Length Polymorphism
            12.4.4.2. Restricted Fragment Length Polymorphism
            12.4.4.3. Single-Stranded Conformation Polymorphism
        12.4.5. MALDI-TOF
        12.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
    12.5. Market Attractiveness, by Technology
    12.6. Market Value Forecast, by Application, 2020-2034
        12.6.1. Pharmacogenomics
        12.6.2. Diagnostic & Personalized Medicine
        12.6.3. Agricultural Biotechnology
        12.6.4. Animal Genetics
        12.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
    12.7. Market Attractiveness, by Application
    12.8. Market Value Forecast, by End-user, 2020-2034
        12.8.1. Pharmaceutical & Biopharmaceutical Companies
        12.8.2. Diagnostic & Research Laboratories
        12.8.3. Academic Institutes
        12.8.4. Others (Animal and Aquagenetics Companies, etc.)
    12.9. Market Attractiveness, by End-user
    12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
        12.10.1. Germany
        12.10.2. U.K.
        12.10.3. France
        12.10.4. Italy
        12.10.5. Spain
        12.10.6. Rest of Europe
    12.11. Market Attractiveness Analysis
        12.11.1. By Product & Service
        12.11.2. By Technology
        12.11.3. By Application
        12.11.4. By End-user
        12.11.5. By Country/Sub-region
13. Asia Pacific Genotyping Assays Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product & Service, 2020-2034
        13.2.1. Reagents & Kits
        13.2.2. Genotyping Services
        13.2.3. Instruments
            13.2.3.1. Sequences & Amplifiers
            13.2.3.2. Analyzers
        13.2.4. Bioinformatics
            13.2.4.1. Software
            13.2.4.2. Services
    13.3. Market Attractiveness, by Product & Service
    13.4. Market Value Forecast, by Technology, 2020-2034
        13.4.1. PCR
            13.4.1.1. Real-time PCR
            13.4.1.2. Digital PCR
        13.4.2. Microarrays
        13.4.3. Sequencing
            13.4.3.1. NGS
            13.4.3.2. Pyrosequencing
            13.4.3.3. Sanger Sequencing
        13.4.4. Capillary Electrophoresis
            13.4.4.1. Amplified Fragment Length Polymorphism
            13.4.4.2. Restricted Fragment Length Polymorphism
            13.4.4.3. Single-Stranded Conformation Polymorphism
        13.4.5. MALDI-TOF
        13.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
    13.5. Market Attractiveness, by Technology
    13.6. Market Value Forecast, by Application, 2020-2034
        13.6.1. Pharmacogenomics
        13.6.2. Diagnostic & Personalized Medicine
        13.6.3. Agricultural Biotechnology
        13.6.4. Animal Genetics
        13.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
    13.7. Market Attractiveness, by Application
    13.8. Market Value Forecast, by End-user, 2020-2034
        13.8.1. Pharmaceutical & Biopharmaceutical Companies
        13.8.2. Diagnostic & Research Laboratories
        13.8.3. Academic Institutes
        13.8.4. Others (Animal and Aquagenetics Companies, etc.)
    13.9. Market Attractiveness, by End-user
    13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
        13.10.1. China
        13.10.2. Japan
        13.10.3. India
        13.10.4. Australia & New Zealand
        13.10.5. Rest of Asia Pacific
    13.11. Market Attractiveness Analysis
        13.11.1. By Product & Service
        13.11.2. By Technology
        13.11.3. By Application
        13.11.4. By End-user
        13.11.5. By Country/Sub-region
14. Latin America Genotyping Assays Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product & Service, 2020-2034
        14.2.1. Reagents & Kits
        14.2.2. Genotyping Services
        14.2.3. Instruments
            14.2.3.1. Sequences & Amplifiers
            14.2.3.2. Analyzers
        14.2.4. Bioinformatics
            14.2.4.1. Software
            14.2.4.2. Services
    14.3. Market Attractiveness, by Product & Service
    14.4. Market Value Forecast, by Technology, 2020-2034
        14.4.1. PCR
            14.4.1.1. Real-time PCR
            14.4.1.2. Digital PCR
        14.4.2. Microarrays
        14.4.3. Sequencing
            14.4.3.1. NGS
            14.4.3.2. Pyrosequencing
            14.4.3.3. Sanger Sequencing
        14.4.4. Capillary Electrophoresis
            14.4.4.1. Amplified Fragment Length Polymorphism
            14.4.4.2. Restricted Fragment Length Polymorphism
            14.4.4.3. Single-Stranded Conformation Polymorphism
        14.4.5. MALDI-TOF
        14.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
    14.5. Market Attractiveness, by Technology
    14.6. Market Value Forecast, by Application, 2020-2034
        14.6.1. Pharmacogenomics
        14.6.2. Diagnostic & Personalized Medicine
        14.6.3. Agricultural Biotechnology
        14.6.4. Animal Genetics
        14.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
    14.7. Market Attractiveness, by Application
    14.8. Market Value Forecast, by End-user, 2020-2034
        14.8.1. Pharmaceutical & Biopharmaceutical Companies
        14.8.2. Diagnostic & Research Laboratories
        14.8.3. Academic Institutes
        14.8.4. Others (Animal and Aquagenetics Companies, etc.)
    14.9. Market Attractiveness, by End-user
    14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
        14.10.1. Brazil
        14.10.2. Mexico
        14.10.3. Rest of Latin America
    14.11. Market Attractiveness Analysis
        14.11.1. By Product & Service
        14.11.2. By Technology
        14.11.3. By Application
        14.11.4. By End-user
        14.11.5. By Country/Sub-region
15. Middle East & Africa Genotyping Assays Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Product & Service, 2020-2034
        15.2.1. Reagents & Kits
        15.2.2. Genotyping Services
        15.2.3. Instruments
            15.2.3.1. Sequences & Amplifiers
            15.2.3.2. Analyzers
        15.2.4. Bioinformatics
            15.2.4.1. Software
            15.2.4.2. Services
    15.3. Market Attractiveness, by Product & Service
    15.4. Market Value Forecast, by Technology, 2020-2034
        15.4.1. PCR
            15.4.1.1. Real-time PCR
            15.4.1.2. Digital PCR
        15.4.2. Microarrays
        15.4.3. Sequencing
            15.4.3.1. NGS
            15.4.3.2. Pyrosequencing
            15.4.3.3. Sanger Sequencing
        15.4.4. Capillary Electrophoresis
            15.4.4.1. Amplified Fragment Length Polymorphism
            15.4.4.2. Restricted Fragment Length Polymorphism
            15.4.4.3. Single-Stranded Conformation Polymorphism
        15.4.5. MALDI-TOF
        15.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
    15.5. Market Attractiveness, by Technology
    15.6. Market Value Forecast, by Application, 2020-2034
        15.6.1. Pharmacogenomics
        15.6.2. Diagnostic & Personalized Medicine
        15.6.3. Agricultural Biotechnology
        15.6.4. Animal Genetics
        15.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
    15.7. Market Attractiveness, by Application
    15.8. Market Value Forecast, by End-user, 2020-2034
        15.8.1. Pharmaceutical & Biopharmaceutical Companies
        15.8.2. Diagnostic & Research Laboratories
        15.8.3. Academic Institutes
        15.8.4. Others (Animal and Aquagenetics Companies, etc.)
    15.9. Market Attractiveness, by End-user
    15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
        15.10.1. GCC Countries
        15.10.2. South Africa
        15.10.3. Rest of Middle East & Africa
    15.11. Market Attractiveness Analysis
        15.11.1. By Product & Service
        15.11.2. By Technology
        15.11.3. By Application
        15.11.4. By End-user
        15.11.5. By Country/Sub-region
16. Competition Landscape
    16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
    16.2. Market Share Analysis, by Company (2023)
    16.3. Company Profiles
        16.3.1. Illumina, Inc.
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Thermo Fisher Scientific
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. QIAGEN N.V.
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Agilent
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Danaher Corporation
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Roche
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. GE HealthCare
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Standard BioTools Inc.
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. PerkinElmer
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. Eurofins Scientific SE
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview
        16.3.11. Bio-Rad Laboratories
            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.11.2. Product Portfolio
            16.3.11.3. Financial Overview
            16.3.11.4. SWOT Analysis
            16.3.11.5. Strategic Overview
        16.3.12. Pacific Biosciences of California, Inc.
            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.12.2. Product Portfolio
            16.3.12.3. Financial Overview
            16.3.12.4. SWOT Analysis
            16.3.12.5. Strategic Overview
        16.3.13. GENEWIZ, Inc.
            16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.13.2. Product Portfolio
            16.3.13.3. Financial Overview
            16.3.13.4. SWOT Analysis
            16.3.13.5. Strategic Overview
        16.3.14. Integrated DNA Technologies, Inc.
            16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.14.2. Product Portfolio
            16.3.14.3. Financial Overview
            16.3.14.4. SWOT Analysis
            16.3.14.5. Strategic Overview